Life insurance growth remained subdued in H1, while health and non-motor business supported gains in the non-life sector amid sweeping regulatory changes.
A prolonged low-rate environment is forcing Chinese insurers to rethink product design, with participating policies emerging as a core strategic and credit-supportive pillar.
Ratings agency cited uncertainty over planned capital injections and ongoing regulatory changes as key factors in its latest review of the Indonesian insurer.
The agency said the changes are unlikely to be meaningful enough in most cases to negatively affect insurers’ credit profiles, even if firms adjust investment, hedging and product design.
Fitch has identified correlated aggregation risk as the key near-term concern for specialty insurers, even as the agency maintains a broadly contained ratings outlook.
The ratings agency has signalled a potential upside for ClearView on account of the acquisition likely enhancing Zurich’s competitiveness in the advised retail life channel, where ClearView maintains a...
